PriceTargets.com logo

Centene - CNC Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $40.00
  • Forecasted Upside: 3.07%
  • Number of Analysts: 21
  • Breakdown:
  • 3 Sell Ratings
  • 15 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$38.81 As of 12/4/2025 04:59 PM ET
+0 (0.00%)

This chart shows the closing price for CNC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Centene Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CNC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CNC

Analyst Price Target is $40.00
▲ +3.07% Upside Potential
This price target is based on 21 analysts offering 12 month price targets for Centene in the last 3 months. The average price target is $40.00, with a high forecast of $73.00 and a low forecast of $28.00. The average price target represents a 3.07% upside from the last price of $38.81.

This chart shows the closing price for CNC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 21 contributing investment analysts is to hold stock in Centene. This rating has held steady since June 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 8 buy ratings
  • 7 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 13 hold ratings
  • 1 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 15 hold ratings
  • 3 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 15 hold ratings
  • 3 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 15 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/21/2025Sanford C. BernsteinReiterated RatingOutperform ➝ Outperform$36.00 ➝ $45.00
11/12/2025Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$41.00 ➝ $35.00
11/4/2025BarclaysSet TargetEqual Weight ➝ Equal Weight$35.00 ➝ $44.00
11/4/2025JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$30.00 ➝ $38.00
11/3/2025Jefferies Financial GroupBoost Target$25.00 ➝ $32.00
10/31/2025CowenReiterated RatingHold ➝ Hold
10/31/2025Deutsche Bank AktiengesellschaftBoost Target$24.00 ➝ $32.00
10/31/2025TD CowenBoost TargetHold ➝ Hold$30.00 ➝ $34.00
10/30/2025UBS GroupSet TargetNeutral ➝ Neutral$31.00 ➝ $42.00
10/30/2025OppenheimerReiterated RatingOutperform ➝ Outperform$45.00
10/30/2025UBS GroupReiterated RatingSell ➝ Sell
10/30/2025The Goldman Sachs GroupReiterated RatingSell ➝ Sell$33.00 ➝ $38.00
10/30/2025Cantor FitzgeraldBoost TargetNeutral ➝ Neutral$38.00 ➝ $41.00
10/30/2025Truist FinancialReiterated RatingBuy ➝ Buy$42.00 ➝ $45.00
10/29/2025Sanford C. BernsteinReiterated RatingOutperform ➝ Outperform
10/29/2025Zacks ResearchUpgradeStrong Sell ➝ Hold
10/14/2025Truist FinancialSet Target$42.00
10/14/2025The Goldman Sachs GroupInitiated CoverageNeutral ➝ Sell$33.00
10/14/2025The Goldman Sachs GroupInitiated CoverageNeutral ➝ Sell$33.00
10/14/2025Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$28.00 ➝ $38.00
10/9/2025MizuhoBoost TargetNeutral ➝ Neutral$28.00 ➝ $40.00
10/8/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
10/7/2025Wells Fargo & CompanySet TargetEqual Weight ➝ Equal Weight$30.00 ➝ $41.00
9/27/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
9/12/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$33.00 ➝ $35.00
9/12/2025Truist FinancialBoost TargetBuy ➝ Buy$35.00 ➝ $39.00
9/5/2025Sanford C. BernsteinLower TargetOutperform ➝ Outperform$40.00 ➝ $36.00
9/4/2025BarclaysSet TargetEqual Weight ➝ Equal Weight$45.00 ➝ $33.00
8/26/2025Cantor FitzgeraldReiterated RatingNeutral ➝ Neutral$38.00
8/4/2025Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$33.00 ➝ $28.00
7/29/2025JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$48.00 ➝ $30.00
7/28/2025Cantor FitzgeraldDowngradeOverweight ➝ Neutral$65.00 ➝ $38.00
7/28/2025UBS GroupLower TargetNeutral ➝ Neutral$45.00 ➝ $31.00
7/28/2025Truist FinancialLower TargetBuy ➝ Buy$42.00 ➝ $35.00
7/28/2025OppenheimerLower TargetOutperform ➝ Outperform$51.00 ➝ $43.00
7/25/2025Robert W. BairdLower TargetNeutral ➝ Neutral$68.00 ➝ $28.00
7/23/2025Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$72.00 ➝ $30.00
7/21/2025TD CowenReiterated RatingBuy ➝ Hold$73.00 ➝ $33.00
7/16/2025Truist FinancialLower TargetBuy ➝ Buy$84.00 ➝ $42.00
7/16/2025Bank of AmericaDowngradeNeutral ➝ Underperform$52.00 ➝ $30.00
7/15/2025OppenheimerLower TargetOutperform ➝ Outperform$85.00 ➝ $51.00
7/11/2025MizuhoLower TargetNeutral ➝ Neutral$71.00 ➝ $40.00
7/10/2025Morgan StanleyDowngradeOverweight ➝ Equal Weight$70.00 ➝ $33.00
7/2/2025Bank of AmericaLower TargetNeutral ➝ Neutral$65.00 ➝ $52.00
7/2/2025BarclaysLower TargetEqual Weight ➝ Equal Weight$65.00 ➝ $45.00
7/2/2025Cantor FitzgeraldLower TargetOverweight ➝ Overweight$90.00 ➝ $65.00
7/2/2025JPMorgan Chase & Co.Reiterated RatingOverweight ➝ Neutral$75.00 ➝ $48.00
7/2/2025UBS GroupReiterated RatingBuy ➝ Neutral$80.00 ➝ $45.00
6/9/2025Morgan StanleyInitiated CoverageOverweight$70.00
6/2/2025BarclaysReiterated RatingOverweight ➝ Equal Weight$84.00 ➝ $65.00
4/29/2025Jefferies Financial GroupLower TargetHold ➝ Hold$64.00 ➝ $61.00
4/29/2025GuggenheimReiterated RatingNeutral ➝ Neutral
4/28/2025BarclaysLower TargetOverweight ➝ Overweight$93.00 ➝ $84.00
4/15/2025Robert W. BairdLower TargetNeutral ➝ Neutral$71.00 ➝ $69.00
4/9/2025GuggenheimInitiated CoverageNeutral
4/8/2025Jefferies Financial GroupUpgradeUnderperform ➝ Hold$53.00 ➝ $64.00
2/14/2025Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$76.00 ➝ $72.00
2/6/2025ArgusDowngradeBuy ➝ Hold
2/4/2025Robert W. BairdBoost Target$66.00 ➝ $71.00
12/17/2024JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Overweight$80.00 ➝ $75.00
12/13/2024StephensLower TargetEqual Weight ➝ Equal Weight$75.00 ➝ $73.00
12/13/2024BarclaysBoost TargetOverweight ➝ Overweight$91.00 ➝ $93.00
12/13/2024Truist FinancialLower TargetBuy ➝ Buy$89.00 ➝ $84.00
12/13/2024OppenheimerLower TargetOutperform ➝ Outperform$95.00 ➝ $85.00
12/13/2024UBS GroupUpgradeNeutral ➝ Buy$79.00 ➝ $80.00
12/11/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
12/10/2024Jefferies Financial GroupDowngradeHold ➝ Underperform$68.00 ➝ $52.00
11/4/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$91.00 ➝ $90.00
10/30/2024Sanford C. BernsteinLower TargetOutperform ➝ Outperform$96.00 ➝ $88.00
10/29/2024BarclaysLower TargetOverweight ➝ Overweight$97.00 ➝ $91.00
10/25/2024Robert W. BairdLower TargetNeutral ➝ Neutral$83.00 ➝ $66.00
10/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
9/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
9/13/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$93.00 ➝ $91.00
9/10/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
9/5/2024BarclaysLower TargetOverweight ➝ Overweight$98.00 ➝ $97.00
8/22/2024BarclaysBoost TargetOverweight ➝ Overweight$90.00 ➝ $98.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
8/5/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$78.00 ➝ $78.00
8/5/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$81.00 ➝ $93.00
8/2/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$82.00 ➝ $87.00
7/31/2024TD CowenBoost TargetBuy ➝ Buy$80.00 ➝ $89.00
7/29/2024OppenheimerLower TargetOutperform ➝ Outperform$110.00 ➝ $95.00
7/24/2024TD CowenLower TargetBuy ➝ Buy$91.00 ➝ $80.00
7/24/2024Jefferies Financial GroupDowngradeBuy ➝ Hold$83.00 ➝ $69.00
7/23/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
7/22/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$93.00 ➝ $81.00
7/15/2024Truist FinancialLower TargetBuy ➝ Buy$92.00 ➝ $89.00
7/11/2024Jefferies Financial GroupLower TargetBuy ➝ Buy$90.00 ➝ $83.00
7/10/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$85.00 ➝ $80.00
6/21/2024OppenheimerReiterated RatingOutperform ➝ Outperform$110.00 ➝ $110.00
6/12/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00 ➝ $90.00
5/30/2024Baird R WUpgradeHold
5/30/2024StephensReiterated RatingEqual Weight ➝ Equal Weight$83.00 ➝ $83.00
5/30/2024Robert W. BairdInitiated CoverageNeutral$83.00
5/2/2024BarclaysBoost TargetOverweight ➝ Overweight$101.00 ➝ $104.00
4/30/2024Deutsche Bank AktiengesellschaftBoost TargetHold ➝ Hold$81.00 ➝ $82.00
4/29/2024OppenheimerReiterated RatingOutperform ➝ Outperform$110.00 ➝ $110.00
4/15/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$89.00 ➝ $93.00
4/8/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$94.00 ➝ $89.00
4/4/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00
3/21/2024StephensReiterated RatingOverweight ➝ Equal Weight$92.00 ➝ $85.00
3/20/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$90.00 ➝ $94.00
3/6/2024BarclaysInitiated CoverageOverweight$101.00
1/2/2024Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$82.00 ➝ $90.00
12/21/2023Truist FinancialBoost TargetBuy ➝ Buy$83.00 ➝ $86.00
12/21/2023UBS GroupBoost TargetNeutral ➝ Neutral$72.00 ➝ $79.00
12/15/2023Cantor FitzgeraldBoost TargetOverweight ➝ Overweight$82.00 ➝ $90.00
12/13/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$74.00 ➝ $82.00
11/21/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$82.00
10/26/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$71.00 ➝ $74.00
10/9/2023Jefferies Financial GroupLower TargetBuy ➝ Buy$82.00 ➝ $81.00
9/14/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$82.00
9/5/2023Bank of AmericaUpgradeUnderperform ➝ Neutral$79.00 ➝ $72.00
8/30/2023Morgan StanleyDowngradeOverweight ➝ Equal Weight$94.00 ➝ $73.00
7/31/2023OppenheimerReiterated RatingOutperform ➝ Outperform$110.00
7/31/2023StephensLower Target$87.00 ➝ $85.00
7/31/2023BarclaysLower TargetOverweight$86.00 ➝ $85.00
7/14/2023Morgan StanleyReiterated RatingOverweight ➝ Overweight$94.00
7/12/2023Wolfe ResearchDowngradeOutperform ➝ Peer Perform
7/11/2023MizuhoLower Target$80.00 ➝ $76.00
7/7/2023JPMorgan Chase & Co.Lower Target$81.00 ➝ $77.00
6/20/2023Truist FinancialLower Target$88.00 ➝ $83.00
6/20/2023UBS GroupInitiated CoverageNeutral$72.00
4/26/2023StephensLower Target$95.00 ➝ $87.00
4/26/2023Credit Suisse GroupLower Target$94.00 ➝ $87.00
4/26/2023BarclaysLower Target$90.00 ➝ $86.00
4/20/2023Cantor FitzgeraldInitiated CoverageOverweight$80.00
4/11/2023BarclaysLower TargetOverweight$93.00 ➝ $90.00
3/21/2023Wells Fargo & CompanyLower TargetEqual Weight$79.00 ➝ $71.00
3/9/2023Morgan StanleyLower TargetOverweight$103.00 ➝ $94.00
3/8/2023Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$94.00 ➝ $79.00
2/28/2023MizuhoLower TargetNeutral$92.00 ➝ $80.00
2/23/2023JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$94.00 ➝ $90.00
2/14/2023CowenLower TargetOutperform$101.00 ➝ $97.00
2/8/2023The Goldman Sachs GroupLower TargetNeutral$97.00 ➝ $74.00
2/8/2023MizuhoReiterated RatingNeutral$92.00
2/8/2023JPMorgan Chase & Co.Lower TargetOverweight$98.00 ➝ $94.00
2/8/2023Loop CapitalLower Target$110.00 ➝ $95.00
2/8/2023BarclaysLower TargetOverweight$100.00 ➝ $93.00
1/6/2023JPMorgan Chase & Co.Lower TargetOverweight$103.00 ➝ $98.00
12/19/2022Credit Suisse GroupBoost TargetOutperform$104.00 ➝ $106.00
12/14/2022ArgusBoost Target$95.00 ➝ $99.00
12/13/2022Bank of AmericaDowngradeNeutral ➝ Underperform$100.00 ➝ $85.00
10/26/2022Deutsche Bank AktiengesellschaftLower Target$99.00 ➝ $94.00
10/3/2022BarclaysLower TargetOverweight$107.00 ➝ $100.00
9/30/2022ArgusInitiated CoverageBuy$90.00
9/22/2022CowenLower Target$108.00 ➝ $101.00
9/22/2022CowenLower Target$108.00 ➝ $101.00
8/26/2022Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$103.00 ➝ $99.00
8/9/2022CowenBoost Target$108.00
7/28/2022BarclaysInitiated CoverageOverweight ➝ Overweight$107.00
7/27/2022StephensBoost TargetOutperform$110.00
7/27/2022OppenheimerBoost TargetOutperform$110.00
7/27/2022Truist FinancialBoost TargetOutperform$102.00 ➝ $110.00
7/27/2022Deutsche Bank AktiengesellschaftBoost Target$91.00 ➝ $99.00
7/19/2022Credit Suisse GroupSet Target$97.00
7/14/2022Jefferies Financial GroupUpgradeHold ➝ Buy$82.00 ➝ $115.00
7/14/2022Truist FinancialBoost TargetBuy$100.00 ➝ $102.00
6/23/2022Morgan StanleyLower TargetOverweight$112.00 ➝ $103.00
6/22/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$88.00 ➝ $91.00
6/21/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform$86.00 ➝ $88.00
6/16/2022Loop CapitalInitiated CoverageBuy$100.00
5/26/2022Sanford C. BernsteinInitiated CoverageOutperform$111.00 ➝ $108.00
5/26/2022Bank of AmericaDowngradeBuy ➝ Neutral$95.00 ➝ $90.00
5/25/2022Wells Fargo & CompanyLower TargetOverweight$96.00 ➝ $95.00
2/9/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$84.00 ➝ $88.00
2/9/2022MizuhoBoost TargetNeutral$78.00 ➝ $84.00
1/11/2022Sanford C. BernsteinBoost Target$94.00 ➝ $108.00
1/7/2022BarclaysInitiated CoverageOverweight ➝ Overweight$95.00
1/5/2022Truist FinancialBoost TargetBuy ➝ Buy$94.00 ➝ $96.00
12/17/2021Morgan StanleyBoost TargetOverweight$86.00 ➝ $109.00
12/14/2021The Goldman Sachs GroupInitiated CoverageNeutral$83.00
12/13/2021Truist FinancialBoost TargetBuy$90.00 ➝ $94.00
12/13/2021Wolfe ResearchBoost TargetOutperform$72.00 ➝ $80.00
12/13/2021StephensBoost TargetOverweight ➝ Overweight$82.00 ➝ $102.00
12/13/2021Bank of AmericaBoost TargetBuy$85.00 ➝ $93.00
12/13/2021OppenheimerBoost TargetOutperform ➝ Outperform$90.00 ➝ $95.00
12/13/2021Wells Fargo & CompanyBoost TargetOverweight$88.00 ➝ $90.00
12/13/2021Credit Suisse GroupBoost TargetNeutral ➝ Neutral$75.00 ➝ $86.00
12/13/2021BMO Capital MarketsBoost TargetOutperform ➝ Outperform$93.00 ➝ $100.00
12/13/2021MizuhoBoost TargetNeutral ➝ Neutral$70.00 ➝ $78.00
11/1/2021CitigroupDowngradeBuy ➝ Neutral$77.00
10/27/2021Credit Suisse GroupBoost TargetNeutral$70.00 ➝ $75.00
10/27/2021Morgan StanleyBoost TargetOverweight$79.00 ➝ $86.00
9/14/2021Credit Suisse GroupLower TargetNeutral$73.50 ➝ $70.00
9/14/2021Morgan StanleyLower TargetOverweight$88.00 ➝ $79.00
9/9/2021CowenInitiated CoverageOutperform$87.00
9/8/2021MizuhoLower TargetNeutral$75.00 ➝ $67.00
8/31/2021Morgan StanleyLower TargetOverweight$94.00 ➝ $88.00
8/17/2021Roth CapitalInitiated CoverageBuy
8/3/2021Wells Fargo & CompanyLower TargetOverweight$93.00 ➝ $88.00
7/9/2021Seaport Res PtnReiterated RatingBuy
6/17/2021CitigroupBoost TargetBuy ➝ Buy$80.00 ➝ $86.00
6/17/2021Wells Fargo & CompanyBoost TargetOverweight$87.00 ➝ $93.00
6/17/2021OppenheimerReiterated RatingBuy$90.00
6/17/2021BMO Capital MarketsBoost TargetPositive ➝ Outperform$88.00 ➝ $93.00
6/17/2021MizuhoBoost TargetNeutral$65.00 ➝ $75.00
6/8/2021Bank of AmericaBoost TargetBuy$75.00 ➝ $85.00
5/24/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00
5/18/2021Wells Fargo & CompanyInitiated CoverageOverweight$87.00
5/11/2021BMO Capital MarketsBoost TargetOutperform$77.00 ➝ $88.00
5/11/2021StephensUpgradeEqual Weight ➝ Overweight$71.00 ➝ $87.00
4/28/2021BMO Capital MarketsLower Target$88.00 ➝ $77.00
3/15/2021MizuhoInitiated CoverageNeutral$65.00
3/9/2021MizuhoInitiated CoverageNeutral$65.00
1/21/2021The Goldman Sachs GroupInitiated CoverageNeutral
1/15/2021Jefferies Financial GroupDowngradeBuy ➝ Hold$75.00 ➝ $72.00
12/21/2020Deutsche Bank AktiengesellschaftLower TargetBuy$83.00 ➝ $77.00
12/14/2020Leerink PartnersLower TargetOutperform$80.00 ➝ $75.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.05 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
8/6/2025
  • 25 very positive mentions
  • 69 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 46 very positive mentions
  • 55 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 69 very positive mentions
  • 48 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 89 very positive mentions
  • 45 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 89 very positive mentions
  • 45 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Centene logo
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $38.81
Low: $38.40
High: $39.00

50 Day Range

MA: $36.54
Low: $33.06
High: $39.72

52 Week Range

Now: $38.81
Low: $25.08
High: $66.81

Volume

4,797,688 shs

Average Volume

8,253,983 shs

Market Capitalization

$19.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Frequently Asked Questions

What sell-side analysts currently cover shares of Centene?

The following equities research analysts have issued stock ratings on Centene in the last twelve months: Argus, Bank of America Corporation, Barclays PLC, Cantor Fitzgerald, Cowen Inc, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer Holdings, Inc., Robert W. Baird, Sanford C. Bernstein, Stephens, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Corporation, UBS Group AG, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for CNC.

What is the current price target for Centene?

0 Wall Street analysts have set twelve-month price targets for Centene in the last year. Their average twelve-month price target is $40.00, suggesting a possible upside of 3.8%. Stephens has the highest price target set, predicting CNC will reach $73.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $28.00 for Centene in the next year.
View the latest price targets for CNC.

What is the current consensus analyst rating for Centene?

Centene currently has 3 sell ratings, 15 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CNC, but not buy more shares or sell existing shares.
View the latest ratings for CNC.

What other companies compete with Centene?

Other companies that are similar to Centene include Elevance Health, Molina Healthcare, Select Medical, Cigna Group and Humana. Learn More about companies similar to Centene.

How do I contact Centene's investor relations team?

Centene's physical mailing address is 7700 FORSYTH BOULEVARD, ST LOUIS MO, 63105. The company's listed phone number is (314) 725-4477 and its investor relations email address is [email protected]. The official website for Centene is www.centene.com. Learn More about contacing Centene investor relations.